Industry Segment and Operations by Geographic Areas - Revenues By Product Type (Detail) (USD $)	3 Months Ended
Mar. 31, 2014	Mar. 31, 2013
Segment Reporting Information [Line Items]
Total revenues	$ 5,202,195	$ 4,528,222
Injection products [Member]
Segment Reporting Information [Line Items]
Total revenues	4,806,782	3,436,500
Transdermal gel products [Member]
Segment Reporting Information [Line Items]
Total revenues	$ 395,413	$ 1,091,722

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration